Join Energy in Action host, Stephanie Tomlinson as she interviews Emil Kakkis and Jessica Riviere from Ultragenyx Pharmaceutical.
On this podcast, Ultragenyx will share how the company entered into LC-FAOD research, its research efforts, and how LC-FAOD patient voices and community engagement are central to the planning, implementation, and advancement of Ultragenyx research and programs. Ultragenyx is proud to partner with MitoAction to provide the LC-FAOD community with information and updates through a series of discussions on MitoAction’s Energy in Action podcast and Monthly Expert Webinar Series.
*This podcast episode is intended for U.S. members of the MitoAction community.*
ENERGY IN ACTION - EPISODE 069 Give Kids the World with Justin Kiser Justin Kiser is a dad to Riley, who is five years...
ENERGY IN ACTION - EPISODE 105 Medical Marijuana for Mitochondrial Disease Dr. Fran Kendall is a Clinical Biochemical Geneticist and Founder of VMP Genetics....
Stephanie Harry and Christine Knox are two powerhouse voices in the mitochondrial disease community, using art as a tool for healing, connection, and empowerment....